Adrenal disease

Prevalence of Adrenal Insufficiency and Adrenal Morphology in Treatment‐Naïve Tuberculosis Patients: A Cross‐Sectional Study From a High‐Burden Region

Clin Endocrinol (Oxf)Published Cross-sectional study

Authors' conclusion

AI is rare (1%) in treatment-naïve TB patients despite the overlapping clinical features in a significant proportion. Subtle adrenal morphological changes without enlargement suggest early TB-related alterations without overt dysfunction. Future research should prioritize larger TB cohorts including Extrapulmonary TB to enhance detection of adrenal pathology while minimizing radiation exposure with detailed immune assessments.

Study context

Population
Adults with newly diagnosed, treatment-naïve tuberculosis (TB) at Revised National Tuberculosis Control Program (RNTCP) clinics, Thiruvananthapuram (Kerala); HIV, uncontrolled DM, critical illness or recent steroid use excluded
Participants
100 adults
Outcome
Prevalence of AI (peak cortisol <17 μg/dL at 60 min and <19.5 μg/dL at 120 min after IM long-acting porcine ACTH)

Main finding

As reported in the abstract

AI prevalence

Adrenal insufficiency (AI) diagnosed (one patient with EPTB)

1

1%

AI in patients with PTB

0

Observational data: associations, not effects.

Further findings

Clinical features suggestive of AI

Patients with clinical features suggestive of AI
27 (27%)

Peak serum cortisol

Mean peak cortisol at 60 min
35.17 ± 10.77 μg/dL
Mean peak cortisol at 120 min
39.67 ± 10.84 μg/dL

Adrenal morphology on CT, TB patients vs healthy controls

Right adrenal Hounsfield unit (HU) density significantly reduced in TB patients vs controls
P = 0.02
Lateral limb thickness significantly reduced in TB patients vs controls
P = 0.01
No adrenal enlargement
  • CT subset: 1 AI patient, 14 TB patients without AI, 18 age-matched healthy controls

Original publication

Prevalence of Adrenal Insufficiency and Adrenal Morphology in Treatment‐Naïve Tuberculosis Patients: A Cross‐Sectional Study From a High‐Burden Region. Clin Endocrinol (Oxf). Published 2 June 2025. doi:10.1111/cen.15282

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.